Metabolic acidosis is a common accompaniment to circulatory arrest. Choosing the right intervention — and knowing when to withhold one — is critical in this setting. The evidence-based approach here differs substantially from routine metabolic acidosis management.
This protocol applies to patients with metabolic acidosis occurring in the context of circulatory arrest. The presence of specific pre-existing conditions significantly shapes the therapeutic decision, and not every patient in this scenario is managed the same way.
Alkalizing therapy is not administered routinely in circulatory arrest. Its use is reserved for select circumstances defined by the patient's pre-existing clinical status — the full protocol details exactly when and how it may be appropriate.
DOI: 10.1053/j.ajkd.2019.01.036